Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies.
Ding X, Ray Chaudhuri A, Callen E, Pang Y, Biswas K, Klarmann KD, Martin BK, Burkett S, Cleveland L, Stauffer S, Sullivan T, Dewan A, Marks H, Tubbs AT, Wong N, Buehler E, Akagi K, Martin SE, Keller JR, Nussenzweig A, Sharan SK.
Ding X, et al. Among authors: sullivan t.
Nat Commun. 2016 Aug 8;7:12425. doi: 10.1038/ncomms12425.
Nat Commun. 2016.
PMID: 27498558
Free PMC article.